Factor VIII prophylaxis for adult patients with severe haemophilia A: Results of a US survey of attitudes and practices

Haemophilia

Volumn 15, Issue 5, 2009, Pages 1014-1021

  Walsh, Christopher E ^a   Valentino, L A ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adults; Haemophilia A; Prophylaxis

Indexed keywords

BLOOD CLOTTING FACTOR 8;

ADULT; AGED; ARTHRITIS; ARTICLE; ATTITUDE TO HEALTH; BLEEDING; BLOOD CLOTTING; CONTROLLED STUDY; DECISION MAKING; DEPRESSION; DIABETES MELLITUS; DISEASE SEVERITY; DRUG COST; DRUG DOSE INCREASE; DRUG SAFETY; DRUG WITHDRAWAL; HEALTH INSURANCE; HEALTH SURVEY; HEMARTHROSIS; HEMOPHILIA A; HEPATITIS A VIRUS; HEPATITIS B VIRUS; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAID; MEDICARE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; TREATMENT RESPONSE; UNITED STATES; VASCULAR ACCESS DEVICE;

ADOLESCENT; ADULT; AGED; BLOOD COAGULATION FACTORS; DRUG ADMINISTRATION SCHEDULE; FACTOR VIII; HEALTH CARE SURVEYS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEMOPHILIA A; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; QUALITY OF HEALTH CARE; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 69949085125     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2009.02036.x     Document Type: Article

References (14)

1. Manco-Johnson MJ, Abshire TC, Shapiro AD et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med 2007; 357: 535-44.
2. Antunes SV, Vicari P, Cavalheiro S, Bordin JO. Intracranial haemorrhage among a population of haemophilic patients in Brazil. Haemophilia 2003; 9: 573-7.
3. Fischer K, van der Bom JG, Molho P et al. Prophylactic versus on-demand treatment strategies for severe haemophilia: A comparison of costs and long-term outcome. Haemophilia 2002; 8: 745-52.
4. Panicker J, Warrier I, Thomas R, Lusher JM. The overall effectiveness of prophylaxis in severe haemophilia. Haemophilia 2003; 9: 272-8.
5. Medical and Scientific Advisory Council, National Hemophilia Foundation. MASAC Recommendation no. 179. MASAC Recommendation concerning prophylaxis (regular administration of clotting factor concentrate to prevent bleeding). 2007. Available at: http://www.hemophilia.org/NHFWeb/ MainPgs/MainNHF.aspx?menuid=57&contentid=1007 (last accessed on 14 April 2009).
6. Srivastava A, Giangrande P, Poon MC, Chua M, McCraw A, Wiedel J. Guidelines for the management of hemophilia. 2006. Available at: http://www.wfh.org/2/docs/Publications/Diagnosis_and_Treatment/ Gudelines_Mng_Hemophilia.pdf (last accessed on 14 April 2009).
7. Berntorp E, Boulyjenkov V, Brettler D et al. Modern treatment of haemophilia. Bull World Health Organ 1995; 73: 691-701.
8. Astermark J. When to start and when to stop primary prophylaxis in patients with severe haemophilia. Haemophilia 2003; 9(Suppl. 1): 32-6. Discussion 7.
9. Richards M, Altisent C, Batorova A et al. Should prophylaxis be used in adolescent and adult patients with severe haemophilia? An European survey of practice and outcome data Haemophilia 2007; 13: 473-9.
10. Geraghty S, Dunkley T, Harrington C, Lindvall K, Maahs J, Sek J. Practice patterns in haemophilia A therapy - global progress towards optimal care. Haemophilia 2006; 12: 75-81.
11. Khair K, Lawrence K, Butler R, O'Shea E, Christie BA. Assessment of treatment practice patterns for severe hemophilia A: A global nurse perspective. Acta Haematol 2008; 119: 115-23.
12. Hay CRM. Prophylaxis in adults with haemophilia. Haemophilia 2007; 13(Suppl. 2):10-5.
13. Tagliaferri A, Franchini M, Coppola A et al. Effects of secondary prophylaxis started in adolescent and adult haemophiliacs. Haemophilia 2008; 14: 945-51.
14. Pipe SW, Valentino LA. Optimizing outcomes for patients with severe hemophilia A. Haemophilia 2007; 13(Suppl. 4): 1-16.